# Decision: Temporary Betty-deferred development continuation

Date: 2026-09-09
Status: Active temporary exception

Decision:
Chris explicitly authorized PRYSM development to continue while Betty is temporarily unavailable. The repaired Solution Directive Authority candidate at `chriskulbaba2025/vantage-platform` SHA `7c0667ae0ad9c893bbc04363e8399e476ce473f0` may be used as the provisional development baseline for the next bounded canonical production-path integration tranche without waiting for an immediate Betty verdict.

Reason:
Betty is temporarily unavailable and the user wants development to continue. The repaired candidate is published, its exact diff is inspectable in GitHub, and the supplied proof records 114/114 focused solution tests, 202/202 existing regressions, and `git diff --check` PASS with no production mutation.

Implication:
This is a development-continuation exception only. It does not retroactively mark the repaired authority tranche as Betty-approved and does not remove the Betty gate from release governance. Deferred Betty review must be caught up before merge to application `main`, deployment, production promotion, provider/model execution, or any other production release action. Intermediate bounded development may proceed through canonical integration while preserving the existing no-merge/no-deploy/no-production-mutation constraints. If a later Betty review returns `REAL PROGRESS — NO`, reopen only the affected dependent tranche(s) and repair the stated defect before release.

Exact provisional baseline:
- Application repository: `chriskulbaba2025/vantage-platform`
- Branch: `review/prysm-solution-directive-authority-betty`
- SHA: `7c0667ae0ad9c893bbc04363e8399e476ce473f0`

Next authorized development tranche:
Determine and implement only the smallest bounded canonical production-path integration seam that consumes the repaired authority boundary plus the accepted canonical solution generator. Do not begin renderer/cross-page work until canonical integration itself is implemented, tested, proven, and published.